Comparison of MnO2 nanoparticles and microparticles distribution in CNS and muscle and effect on acute pain threshold in rats


1 Department of Biology, Basic Sciences School, Shahed University, Tehran, Iran

2 Department of Pharmacology, Faculty of Pharmaceutical Sciences, Islamic Azad University, Tehran, Iran



Recently, applications of MnO2 nanoparticles and microparticles in industry, pharmacology, and medicine have considerably expanded. Mn distribution and clearance from brain and spinal cord tissue compared with muscle tissue of rats after single subcutaneous injection of nanoparticles and microparticle of MnO2. Pain sensory threshold of rat was evaluated as neurologic consequence of the particles on CNS activity of rats.
Materials and Methods:
Rats divided to control and two experimental groups. Each experimental group received a single subcutaneous injection of MnO2 nano and micro particles, respectively. Acute pain thresholds of rats were evaluated by tail immersion method and its weight gain was recorded during these weeks. Samples taken from brain, spinal cord and muscle tissues of rats, once every 2 week for 8 weeks. The tissue Mn level was measured by inductively coupled plasma-mass spectrometry method.  
Both particles size passed from blood barriers. Unlike brain tissue, manganese completely cleared from spinal tissue after 8 weeks in both groups. Clearance of Mn from muscle tissue is not complete in both of the groups. Weight gain of rats in both groups was slower than control rats. In microparticle group, rats showed progressive analgesia (p<0.05). In nanoparticle groups, rats showed hyperalgesia for first 4 weeks and analgesia during remaining weeks.
Change in MnO2 particles size affect on Mn distribution and clearance from central nervous system. Effect of particles on whole body metabolism varied with its size too. Finally, comparison of pain response of rats among particle treated groups indicates that neurobiological mechanism affected by particles is varied with their size during times after administration.


1. Allaker RP, Ren G. Potential impact of nanotechnology on the control of infectious diseases. Trans R Soc Trop Med Hyg. 2008; 102(1): 1-2.

2. Prasad B, Mondal KK. Environmental impact of manganese due to its leaching from coal fly ash. J Environ Sci Eng. 2009; 51(1): 27-32.

3. Najafpour MM, Rahimi F, Aro EM, Lee CH, Allakhverdiev SI. Nano-sized manganese oxides as biomimetic catalysts for water oxidation in artificial photosynthesis: a review. J R Soc Interface. 2012; 9(75): 2383-2395.

4. Davis CD, Wolf TL, Greger JL. Varying levels of manganese and iron affect absorption and gut endogenous losses of manganese by rats. J Nutr. 1992; 122(6): 1300-1308.

5. Na HB, Lee JH, An K, Park YI, Park M, Lee IS, et al. Development of a T-1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl. 2007; 46(28): 5397-5401.

6. Roels H, Meiers G, Delos M, Ortega I, Lauwerys R, Buchet JP, et al. Lison, Influence of the route of administration and the chemical form (MnCl2, MnO2) on the absorption and cerebral distribution of manganese in rats. Arch Toxicol. 1997; 71(4): 223-230.

7. Oszlánczi G, Vezér T, Sárközi L, Horváth E, Kónya Z, Papp A. Functional neurotoxicity of Mn-containing nanoparticles in rats. Ecotoxicol Environ Saf. 2010; 73(8): 2004-2009.

8. Wang SH, Shih YL, Kuo TC, Ko WC, Shih CM. Cadmium toxicity toward autophagy through ROS-activatied GSK- 3beta in mesangial cells. Toxicol Sci. 2009; 108(1): 124-131.

9. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006; 311(5761): 622-627.

10. Bowler RM, Roels HA, Nakagawa S, Drezgic M, Diamond E, Park R, et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med. 2007; 64(3): 167-177.

11. Lison D, Lardot C, Huaux F, Zanetti G, Fubini B. Influence of particle surface area on the toxicity of insoluble manganese dioxide dusts. Arch Toxicol. 1997; 71(12): 725-729.

12. Schmidt C, Lautenschlaeger C, Collnot EM, Schumann M, Bojarski C, Schulzke JD, et al. Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa-A first in vivo study in human patients. J Control Release. 2013; 165(2): 139-145.

13. J Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci. 2006; 89(1): 338-347.

14. Nishiyama K, Suzuki Y, Fujii N, Yano H, Ohnishi K, Miyai T. Biochemical changes and manganese distribution in monkeys exposed to manganese dioxide dust. Tokushima J Exp Med. 1977; 24(3-4): 137-145.

15. Li Y, Tian X, Lu Z, Yang C, Yang G, Zhou X, et al. Mechanism for α-MnO2 nanowire-induced cytotoxicity in Hela Cells. J Nanosci Nanotechnol. 2010; 10(1): 397-404.

16. Muthu MS, Singh S. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine (Lond). 2009; 4(1): 105-118.

17. Sarkozy L, Horvath E, Szabo A, Horvath E, Sapi A, Konya Z, et al. Neurotoxic effects of metal oxide nanoparticles on the somatosensory system of rats following subacute intratracheal application. CEJOEM. 2008; 14(3): 277-290.

18. Yang Z, Liu ZW, Allaker RP, Reip P, Oxford J, Ahmad Z, et al. A review of nanoparticle functionality and toxicity on the central nervous system. J R Soc Interface. 2010; 7 Suppl 4: S411-422.

19. Wang J, Chen C, Liu Y, Jiao F, Li W, Lao F, et al. Potential neurological lesion after nasal instillation of TiO2 nanoparticles in the anatase and rutile crystal phases. Toxicol Lett. 2008; 183(1-3): 72-80.

20. Flores JA, El Banoua F, Galلn-Rodrیguez B, Fernandez-Espejo E. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Pain. 2004; 110(1-2): 205-214.

21. You H, Zhao J, Li L, Yuan J. Effects of MnO2 Nanoparticles on Liver and Kidney Cells of Rats. Proceedings of the 5th International Conference on Bioinformatics and Biomedical Engineering (iCBBE) 2011; May 10-12; Wuhan, China, p. 1-4.

22. Zhang Y, Yang Y, Zhang Y, Zhang T, Ye M. Heterogeneous oxidation of naproxen in the presence of α-MnO2 nanostructures with different morphologies. Appl. Catal. B. 2012; 127: 182-189.

23. Vanhoe H. A review of the capabilities of ICP-MS for trace element analysis in body fluids and tissues. J Trace Elem Electrolytes Health Dis. 1993; 7(3): 131-139.

24. Niazi SB, Littlejohn D, Halls DJ. Rapid partial digestion of biological tissues with nitric acid for the determination of trace elements by atomic spectrometry. Analyst. 1993; 118(7): 821-825.

25. Pearson GF, Greenway GM. Recent developments in manganese speciation. Trends Anal Chem. 2005; 24(9): 803-809.

26. Baluchnejadmojarad T, Roghani M. Chronic oral epigallocatechin-gallate alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: involvement of oxidative stress. Iran. J Pharm Res. 2012; 11 (4): 1243-1253.

27. Yang In Kim, Heung Sik Na, Jung Soo Han, and Seung Kil Hong. Critical role of the capsaicin-sensitive nerve fibers in the development of the causalgic symptoms produced by transecting some but not all of the nerves innervating the rat tail. J Neurosci. 1995; 75(6): 4133-4139.

28. Takeda A. Manganese action in brain function: Review. Brain Res Brain Res Rev. 2003; 41(1): 79-87.

29. Santamaria AB. Manganese exposure, essentiality & toxicity. Indian J Med Res. 2008; 128(4): 484-500.

30. Reaney SH, Bench G, Smith DR. Brain accumulation and toxicity of Mn(ii) and Mn(iii) exposures. Toxicol Sci. 2006 Sep; 93(1):114-124.

31. Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006; 114(8): 1172-1178.

32. Brenneman KA, Wong BA, Buccellato MA, Costa ER, Gross EA, Dorman DC. Direct olfactory transport of inhaled manganese ((54)MnCl(2)) to the rat brain: toxicokinetic investigations in a unilateral nasal occlusion model. Toxicol Appl Pharmacol. 2000; 169(3): 238-248.

33. Gu L, Fang RH, Sailor MJ, Park JH. In Vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano. 2012; 6(6): 4947-4954.

34. Sharma HS, Sharma A. Breakdown of the blood-brain barrier in stress alters cognitive dysfunction and induced brain pathology, new perspective for neuroprotective strategies. In: Michel Ritsner, editor., Brain Protection in Schizophrenia, Mood and Cognitive Disorders, Volume 1. Netherlands: Springer; 2010. p. 243-304.

35. Gallez B, Demeure R, Baudelet C, Abdelouahab N, Beghein N, Jordan B, et al. Non invasive quantification of manganese deposits in the rat brain by local measurement of NMR proton T1 relaxation times. Neurotoxicology. 2001; 22(3): 387-392.

36. Takeda A, Sawashita J, Okada S. Localization in rat brain of the trace metals, zinc and manganese, after intracerebroventricular injection. Brain Res. 1994; 658(1-2): 252-254.

37. Amrite AC, Kompella UB. Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol. 2005; 57(12): 1555-1563.

38. Balasubramanian SK, Jittiwat J, Manikandan J, Ong CN, Yu LE, Ong WY. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials. 2010; 31(8): 2034-2042.

39. Warheit DB, Hoke RA, Finlay C, Donner EM, Reed KL, Sayes CM. Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management. Toxicol Lett. 2007; 171(3): 99-110.

40. Szalay B, Tلtrai E, Nyیrő G, Vezér T, Dura G. Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments. J Appl Toxicol. 2012; 32(6): 446-453.

41. Brieger K, Schiavone S, Miller FJ Jr, Krause KH. Reactive oxygen species: from health to disease. Swiss Med Wkly. 2012; 142: w13659. Available from URL: doi:10.4414/smw.2012.13659

42. Stefanescu DM, Khoshnan A, Patterson PH, Hering JG. Neurotoxicity of manganese oxide nanomaterials. J Nanopart Res. 2009; 11(8): 1957-1969.

43. van Rijn RM, Brissett DI, Whistler JL. Emergence of functional spinal delta opioid receptors after chronic ethanol exposure. Biol Psychiatry. 2012; 71(3): 232-238.

44. Yin QQ, Wu L, Gou ML, Qian ZY, Zhang WS, Liu J. Long-lasting infiltration anaesthesia by lidocaine-loaded biodegradable nanoparticles in hydrogel in rats. Acta Anaesthesiol Scand. 2009; 53(9): 1207-1213.

45. Ahmadi A, Khalili M, Mihandoust F, Barghi L. Synthesis and determination of acute and chronic pain activities of 1-[1-(3-methylphenyl) (tetralyl)]piperidine as a new derivative of phencyclidine via tail immersion and formalin tests. Arzneimittelforschung. 2010; 60(1): 30-5.

46. Fernandes A, Brites D. Contribution of inflammatory processes to nerve cell toxicity by bilirubin and efficacy of potential therapeutic agents. Curr Pharm Des. 2009; 15(25): 2915-2926.

47. Bird ED, Anton AH, Bullock B. The effect of manganese inhalation on basal ganglia dopamine concentration in rhesus monkey, Neurotoxicology. 1984; 5(1): 59-65.

48. Wang J, Rahman MF, Duhart HM, Newport GD, Patterson TA, Murdock RC, et al. Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxic ology. 2009; 30(6): 926-933.

49. Liu QS, Qiao JT, Dafny N. D2 dopamine receptor involvement in spinal dopamine-produced antinociception. Life Sci. 1992; 51(19): 1485-1492.

50. Barasi S, Ben-Sreti MM, Clatworthy AL, Duggal KN, Gonzalez JP, Robertson J, et al. Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390. Br J Pharmacol. 1987; 90(1): 15-22.

51. Gao X, Xin BM, Zhu CB, Wu GC, Xu SF. Effect of intrathecal injection of dopamine receptor agonists/antagonists on pain and acupuncture analgesia in rats. Sheng Li Xue Bao. 1998; 50(1): 43-48.

52. Greco R, Tassorelli C, Armentero MT, Sandrini G, Nappi G, et al. Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia. Brain Res. 2008; 1238: 215-223.

53. Borsook D, Upadhyay J, Chudler EH, Becerra L. A key role of the basal ganglia in pain and analgesia - insights gained through human functional imaging. Mol Pain. 2010; 6: 27.

54. Wang J, Liu Y, Jiao F, Lao F, Li W, Gu Y, et al. Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO2 nanoparticles. Toxicology. 2008; 254(1-2): 82-90.

55. Sلrkِzi L, Horvلth E, Kَnya Z, Kiricsi I, Szalay B, Vezér T, et al. Subacute intratracheal exposure of rats to manganese nanoparticles: behavioral, electrophysiological, and general toxicological effects. Inhal Toxicol. 2009; 21 Suppl 1: 83-91.

56. Hudspith MJ, Harrisson S, Smith G, Bountra C, Elliot PJ, Birch PJ, Hunt SP, Munglani R. Effect of post-injury NMDA antagonist treatment on long-term Fos expression and hyperalgesia in a model of chronic neuropathic pain. Brain Res. 1999; 822(1-2): 220-227.